Skip to main content

Matthew Robinson

Equibles does not estimate personal net worth.

Get an email with a short summary when Immunome Inc. publishes a filing, an earnings call transcript or a press release.

Get IMNM alerts

About Matthew Robinson

Immunome Inc. reported in an 8-K filed October 4, 2023 that Matthew Robinson was appointed Chief Discovery Officer, Biology, effective October 2, 2023. Immunome Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Immunome Inc. includes Clay B. Siegall, Ph.D. (CEO), Clay Siegall (CEO), Corleen Roche (CFO) and 7 others.

“Immediately following the effective time of the Merger, Immunome's board of directors (and its committees) and executive officers were reconstituted to include the following directors and executive officers”
Immunome Inc. Form 8-K, filed October 4, 2023 · Read the filing

Affiliation history

Company network

Leadership on record at Immunome Inc.

Recent activity